Onyx Sues Partner Bayer Over New Cancer Treatment
Onyx Pharmaceuticals Inc. has sued Bayer AG, accusing its longtime partner of surreptitiously developing a successor treatment to their joint cancer drug Nexavar....To view the full article, register now.
Already a subscriber? Click here to view full article